After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.

These stocks have both short-term gain catalysts and longer-term growth potential.

Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.

Stryker must significantly outperform for all of 2015 just to meet expectations. That's a tall order.

Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.

As mortgage rates hit fresh highs, there's something unusual going on with the real estate market.

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.